Finance

Lists
543960:BOM
Concord Biotech Ltd
၁,၃၃၉.၈၅ ₹
-၀.၉၉%
(-၁၃.၄၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543960...
Open
၁,၃၅၅.၀၀ ₹
High
၁,၃၅၅.၉၅ ₹
Low
၁,၃၃၃.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၀ သ
Avg. vol.
၁.၀၁ သောင်း
Volume
၁.၂၇ ထောင်
Dividend
၀.၅၆%
Quarterly dividend
၁.၈၉ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၅၀.၉၃
52-wk high
၁,၆၁၄.၀၅ ₹
52-wk low
၉၈၇.၀၅ ₹
EPS
၂၆.၃၁ ₹
No. of employees
၂ ထောင်
Open
၁,၃၅၅.၀၀ ₹
High
၁,၃၅၅.၉၅ ₹
Low
၁,၃၃၃.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၀ သ
Avg. vol.
၁.၀၁ သောင်း
Volume
၁.၂၇ ထောင်
Dividend
၀.၅၆%
Quarterly dividend
၁.၈၉ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၅၀.၉၃
52-wk high
၁,၆၁၄.၀၅ ₹
52-wk low
၉၈၇.၀၅ ₹
EPS
၂၆.၃၁ ₹
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၄ နာရီ
Behavioral Patterns of JMKE and Institutional Flows
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
Dow Jones, Nasdaq 100, S&P 500 Outlook: Top Catalysts to Move US Stocks This Week
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
Did FDA Filings Just Shift Cogent Biosciences Stock Investment Narrative?
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide. It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd
CEO-
Employees၁.၆၂ ထောင်
Founded၂၀၀၀
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၄၇.၀၆ ဋေ
၂၇၇.၇၇ ဋေ
၃၂၆.၀၈ ဋေ
၂၅၇.၄၉ ဋေ
Cost of goods sold
၇၇.၅၄ ကုဋေ
၉၄.၁၇ ကုဋေ
၁၃၂.၀၃ ဋေ
၈၉.၀၁ ကုဋေ
Cost of revenue
၇၇.၅၄ ကုဋေ
၉၄.၁၇ ကုဋေ
၁၃၂.၀၃ ဋေ
၈၉.၀၁ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄၄.၄၆ ကုဋေ
၄၆.၇၈ ကုဋေ
၄၇.၇၇ ကုဋေ
၄၃.၆၄ ကုဋေ
Operating expense
၉၉.၄၁ ကုဋေ
၁၀၃.၃၆ ဋေ
၈၃.၇၁ ကုဋေ
၁၀၄.၂၀ ဋေ
Total operating expenses
၁၇၆.၉၆ ဋေ
၁၉၇.၅၃ ဋေ
၂၁၅.၇၄ ဋေ
၁၉၃.၂၁ ဋေ
Operating income
၇၀.၁၀ ကုဋေ
၈၀.၂၃ ကုဋေ
၁၁၀.၃၄ ဋေ
၆၄.၂၈ ကုဋေ
Other non operating income
၁၃.၃၅ ကုဋေ
၉.၉၈ ကုဋေ
-၃၅.၆၃ ကုဋေ
၁၂.၈၃ ကုဋေ
EBT including unusual items
၈၅.၆၈ ကုဋေ
၈၆.၁၆ ကုဋေ
၁၁၄.၀၈ ဋေ
၇၈.၃၄ ကုဋေ
EBT excluding unusual items
၈၅.၆၈ ကုဋေ
၈၉.၄၃ ကုဋေ
၉၂.၉၃ ကုဋေ
၇၈.၃၄ ကုဋေ
Income tax expense
၂၂.၆၂ ကုဋေ
၂၂.၅၁ ကုဋေ
၂၅.၆၁ ကုဋေ
၂၀.၆၅ ကုဋေ
Effective tax rate
၂၆.၄၀%
၂၆.၁၃%
၂၂.၄၅%
၂၆.၃၅%
Other operating expenses
၃၆.၅၇ ကုဋေ
၃၇.၈၃ ကုဋေ
၁၆.၄၀ ကုဋေ
၄၂.၄၆ ကုဋေ
Net income
၆၃.၅၈ ကုဋေ
၆၄.၄၈ ကုဋေ
၈၈.၇၉ ကုဋေ
၅၈.၅၃ ကုဋေ
Net profit margin
၂၅.၇၄%
၂၃.၂၁%
၂၇.၂၃%
၂၂.၇၃%
Earnings per share
၆.၀၃
၆.၃၁
၈.၄၆
၅.၅၂
Interest and investment income
-
-
၂.၄၆ ကုဋေ
-
Interest expense
-၅.၉၁ သိန်း
-၈.၁၅ သိန်း
-၈.၄၀ သိန်း
-၃.၆၄ သိန်း
Net interest expenses
-၅.၉၁ သိန်း
-၈.၁၅ သိန်း
၂.၃၈ ကုဋေ
-၃.၆၄ သိန်း
Depreciation and amortization charges
၁၈.၃၉ ကုဋေ
၁၈.၇၅ ကုဋေ
၁၉.၅၄ ကုဋေ
၁၈.၁၀ ကုဋေ
EBITDA
၈၈.၁၈ ကုဋေ
၉၃.၃၉ ကုဋေ
၁၂၈.၄၉ ဋေ
၈၂.၄၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ